Selegiline
- 1 December 1996
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 47 (6_suppl_3) , 210S-216S
- https://doi.org/10.1212/wnl.47.6_suppl_3.210s
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotoxicity In VitroJournal of Neurochemistry, 1997
- l‐Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor‐Mediated Toxicity In VitroJournal of Neurochemistry, 1997
- Selegiline and mortality in Parkinson's diseaseAnnals of Neurology, 1996
- Searching for gastrinomas.BMJ, 1993
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐TetrahydropyridineJournal of Neurochemistry, 1987
- In the Beginning: To Celebrate 20 Years of the International Society for Neurochemistry (ISN)Journal of Neurochemistry, 1985
- Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmissionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Lymphocyte blast transformation responses to mitogens and specific antigens in different clinical phases of multiple sclerosis: a follow-up studyActa Neurologica Scandinavica, 1983
- The effect of β-alanine on motor behaviour, body temperature and cerebral monoamine metabolism in ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978